Aptamer

APTA.L

Tags: GB Healthcare Biotechnology

Aptamer Group plc Price (APTA.L)

Stock Price

Low: Year Low

High: Year High

Market Cap

Fetching Data...

Enterprise Value

Fetching Data...

Shares Outstanding

415,107,581

(501.1228)%

Market Cap of Aptamer (APTA.L)

Market cap:

As of , APTA.L has a market cap of . This makes APTA.L the 1111th most valuable company in the GB by market cap. Market capitalization, or market cap, is the total value of a company's outstanding shares of stock, calculated by multiplying the current stock price by the total number of shares.

Year

Beginning Of Year

End Of Year

YOY Change

Community Sentiment 0 votes

↑ 0% ↓ 0%

Description

Aptamer Group plc provides binders for research, diagnostics, and therapeutics in the United Kingdom and internationally. The company's binders engineered to address issues which founds with molecules, such as antibodies; and offers solutions to bioprocessing, diagnostic, and pharmaceutical scientists. It serves pharma companies, diagnostic development companies, and research institutes. The company was incorporated in 2014 and is based in York, the United Kingdom. Read More

Sector: Healthcare

Previous Close Fetching Data...
Range $0.2-0.95
Market Cap 6.17M
Enterprise Value No Data
Avg Volume Fetching Data...
P/E Ratio Fetching Data...
Dividend Yield Fetching Data...

Industry: Biotechnology

ceo: Dr. Arron Craig Tolley
IPO Date: December, 22, 2021
Country: GB
Currency: GBp
Headquaters: No Data
Employees: 28

- Revenue from each product or segment:

Product or Segment	Value:	% - Total	Last 3Y:

- Revenue by Region

Product or Segment	Value:	% - Total	Last 3Y: